NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 GOLD Q1 2026 Earnings EPS Crushes Estimates with 61 Surprise Yet Stock Dips cbdMD Inc YCBD Q1 2026 Earnings WiderThanExpected Loss Highlights Ongoing Challenges Algorhythm Holdings Inc RIME Q1 2026 Earnings Beats EPS Estimates Despite No Reported Revenue MGRC Q1 2026 Earnings EPS Falls Short of Estimates Shares Inch Higher OMER Q1 2026 Earnings Significant EPS Beat Amid Pipeline Progress